4.7 Review

HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

The IPD-IMGT/HLA Database

Dominic J. Barker et al.

Summary: The IPD-IMGT/HLA Database is a searchable repository of highly curated HLA sequences for the HLA community. With the adoption of Next Generation Sequencing technology, the database has grown in size, prompting the development of tools for enhanced user experience and programmatic access.

NUCLEIC ACIDS RESEARCH (2023)

Review Immunology

The impact of immunopeptidomics: From basic research to clinical implementation

Ilja E. Shapiro et al.

Summary: The immunopeptidome is a collection of peptides presented by MHC molecules on the surface of cells involved in T-cell immunosurveillance. It provides information about the cellular health state and is influenced by various factors. Immunopeptidomics is the method used to extract and analyze these peptides, giving insights into the immunopeptidome.

SEMINARS IN IMMUNOLOGY (2023)

Review Immunology

Viral T-cell epitopes - Identification, characterization and clinical application

Sarah M. Schroeder et al.

Summary: T-cell immunity is crucial for controlling viral infections, and it involves the CD4+ and CD8+ T cells. The viral T-cell epitopes, which are viral peptides presented by human leukocyte antigen (HLA) on virus-infected cells, are essential for T cell recognition of infected cells. Understanding viral T-cell epitopes not only offers a diagnostic tool to study protective T-cell responses in the human population, but also provides potential prophylactic and therapeutic options, such as vaccination and transfer of virus-specific T cells. These approaches have demonstrated effectiveness against various viral infections, especially in immunocompromised patients with insufficient antibody-based immune responses.

SEMINARS IN IMMUNOLOGY (2023)

Review Immunology

The T cell immune response against SARS-CoV-2

Paul Moss

Summary: T cell immunity plays a central role in controlling SARS-CoV-2 infection, with early responses correlating with protection. T cell memory provides broad recognition of viral proteins, limiting the impact of viral variants and offering protection against severe disease. Current COVID-19 vaccines elicit robust T cell responses, contributing to the prevention of hospitalization or death. Therefore, the importance of T cell immunity may have been underestimated.

NATURE IMMUNOLOGY (2022)

Review Immunology

Protective neutralizing epitopes in SARS-CoV-2

Hejun Liu et al.

Summary: The COVID-19 pandemic has caused a global health crisis and economic burden. The SARS-CoV-2 virus, a new member of the coronavirus family, has infected hundreds of millions of people worldwide. Over the past 2 years, it has evolved to increase transmissibility and evade immunity from previous infection and vaccination. Immune responses from viral infection and vaccination have proven to be protective against variants, especially in terms of hospitalization or severe disease.

IMMUNOLOGICAL REVIEWS (2022)

Article Microbiology

Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection

Li-na Yan et al.

Summary: This study found that COVID-19 patients had persistent neutralizing antibody and memory T-cell responses to SARS-CoV-2 after 1.5 years, indicating that these sustained immune responses may play a crucial role in protection against reinfection.

FRONTIERS IN MICROBIOLOGY (2022)

Review Immunology

T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles

Luca Hensen et al.

Summary: This article discusses the complexity of CD8(+) T cell immune response and the use of immunopeptidomics approach to identify CD8(+) T cell epitopes restricted by specific HLA allotypes. The focus is on the identification of influenza-specific CD8(+) T cell epitopes in Indigenous Australians to improve vaccine coverage and efficacy.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

The coding capacity of SARS-CoV-2

Yaara Finkel et al.

Summary: A high-resolution map of coding regions in the SARS-CoV-2 genome enables the identification of 23 unannotated open reading frames and quantification of the expression of canonical viral open reading frames.

NATURE (2021)

Article Immunology

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde et al.

Summary: SARS-CoV-2-specific T cell epitopes were identified in convalescent and unexposed individuals, showing cross-reactivity with common cold coronaviruses. The diversity of SARS-CoV-2 T cell responses may be associated with mild symptoms of COVID-19.

NATURE IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Lauren B. Rodda et al.

Summary: The study found that individuals recovered from mild COVID-19 develop sustained SARS-CoV-2-specific immunological memory for at least 3 months, including immunoglobulin antibodies, neutralizing plasma, and memory B and T cells. These memory lymphocytes exhibit potent antiviral function, aiding in immune defense.
Correction Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (vol 586, pg 589, 2020)

Mark J. Mulligan et al.

NATURE (2021)

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Editorial Material Immunology

Antigenic drift: Understanding COVID-19

Jonathan W. Yewdell

IMMUNITY (2021)

Article Biochemistry & Molecular Biology

Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 spike glycoprotein

George Stamatakis et al.

Summary: The study analyzed the processing of antigenic peptides by different allotypes of endoplasmic reticulum aminopeptidase 1 (ERAP1) in coronavirus disease 2019, revealing significant differences in peptide sequences produced by different allotypes, which may contribute to variable immune responses.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?

Silvia D'Amico et al.

Summary: COVID-19 patients exhibit a wide range of clinical outcomes, from asymptomatic to severe respiratory syndrome. Identifying prognostic factors can help improve risk stratification and determine the most effective treatment. Dysfunctional status of ERAP1 and ERAP2 enzymes may exacerbate the effects of SARS-CoV-2 infection, worsening symptoms and clinical outcomes of the disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Antibody evasion by the P.1 strain of SARS-CoV-2

Wanwisa Dejnirattisai et al.

Summary: Ending the SARS-CoV-2 pandemic requires global vaccination. New virus strains with mutations impact antibody responses, but some variants are less resistant than others. A monoclonal antibody can neutralize different variants and partially restore neutralization potency for other public antibodies.
Article Immunology

Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms

Irma Saulle et al.

Summary: HLA molecules play a crucial role in host immune response and specific correlations have been established between certain HLA alleles and SARS-CoV-2 infection. Despite some confusion and contradictions in the data, the research aims to partially untangle this complex relationship.

HUMAN IMMUNOLOGY (2021)

Article Biochemical Research Methods

Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies

Chen Li et al.

Summary: This study utilized tandem mass spectrometry and proteomic techniques to analyze a dataset of MS/MS spectra derived from synthetic peptides of SARS-CoV-2, creating an online knowledgebase called virusMS. The database provides detailed annotations of peptides, experimental information, and predicted peptide-HLA binding affinities, aiding in vaccination target identification and immune monitoring research. VirusMS offers a user-friendly interface for easy access to the database content.

PROTEOMICS (2021)

Article Cell Biology

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich et al.

Summary: The study found that antibody responses in COVID-19 convalescent individuals decreased or remained stable within 6 months, while T cell responses showed a robust increase. T cell responses included key epitopes that mediate long-term SARS-CoV-2 immunity.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Immunology

Cellular Immune Response to COVID-19 and Potential Immune Modulators

Xi Zhou et al.

Summary: The severity of COVID-19 is mainly related to host factors, especially cellular immune responses in patients. Treatment recommendations are tailored based on the dynamics of immune responses, including administering appropriate medications at different stages.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients

Sunil Kumar Saini et al.

Summary: This study experimentally evaluated MHC class I-binding peptides covering the complete SARS-CoV-2 genome, revealing significant CD8(+) T cell recognition of SARS-CoV-2 epitopes in patients with COVID-19, coupled with strong activation features in these T cells. Compared to healthy individuals, patients with severe disease displayed larger populations of SARS-CoV-2-specific T cells.

SCIENCE IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

Shira Weingarten-Gabbay et al.

Summary: T cell-mediated immunity plays a crucial role in controlling SARS-CoV-2 infection, with some peptides derived from internal out-of-frame ORFs in spike and nucleocapsid eliciting stronger T cell responses than canonical peptides. Early expressed viral proteins contribute more to HLA-I presentation and immunogenicity, providing insights for vaccine development and immune monitoring.
Article Cell Biology

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

Adi Nagler et al.

Summary: This study identified SARS-CoV-2-derived peptides presented by HLA-I and HLA-II molecules, some of which are immunogenic, potentially aiding in the development of next-generation SARS-CoV-2 vaccines.

CELL REPORTS (2021)

Review Infectious Diseases

Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials

Musha Chen et al.

Summary: A systematic review and meta-analysis found that the safety and tolerance of current COVID-19 vaccine candidates are acceptable for mass vaccination, with inactivated COVID-19 vaccines candidates having the lowest reported adverse events following immunization (AEFI). Long-term surveillance of vaccine safety is required, especially among elderly people with underlying medical conditions.

INFECTIOUS DISEASES OF POVERTY (2021)

Article Immunology

Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination

Lisa Mueller et al.

Summary: The study compared antibody responses to the BNT162b2 COVID-19 vaccine in young vaccinees below 60 and elderly vaccinees over 80. The elderly group had lower antibody titers and a lower frequency of neutralizing antibodies post-vaccination, indicating a potential need for closer monitoring or different vaccination strategies for this population.

CLINICAL INFECTIOUS DISEASES (2021)

Article Cell Biology

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

Marios Koutsakos et al.

Summary: The study found that the immune response in COVID-19 patients differs between the acute phase and convalescent phase, with more severe immune activation and cellular hyperactivation in critically ill patients. The research also revealed the crucial role of activated CXCR3(+)cT(FH)1 cells in predicting antibody levels and neutralization activity.

CELL REPORTS MEDICINE (2021)

Article Cell Biology

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

Alison Tarke et al.

Summary: By studying T cell responses in 99 convalescent COVID-19 cases, we identified various HLA-restricted epitopes derived from SARS-CoV-2 and observed distinct patterns of immunodominance. The epitopes were combined into megapools to facilitate the identification and quantification of virus-specific CD4(+) and CD8(+) T cells.

CELL REPORTS MEDICINE (2021)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Biotechnology & Applied Microbiology

A large peptidome dataset improves HLA class I epitope prediction across most of the human population

Siranush Sarkizova et al.

NATURE BIOTECHNOLOGY (2020)

Article Immunology

Identification of antigens presented by MHC for vaccines against tuberculosis

Paulo Bettencourt et al.

NPJ VACCINES (2020)

Article Biochemistry & Molecular Biology

The Architecture of SARS-CoV-2 Transcriptome

Dongwan Kim et al.

Review Immunology

Immunology of COVID-19: Current State of the Science

Nicolas Vabret et al.

IMMUNITY (2020)

Article Genetics & Heredity

Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2

Kazuma Kiyotani et al.

JOURNAL OF HUMAN GENETICS (2020)

Article Microbiology

SARS-CoV-2 detection in patients with influenza-like illness

Wen-Hua Kong et al.

NATURE MICROBIOLOGY (2020)

Review Cell Biology

An Overview on ERAP Roles in Infectious Diseases

Irma Saulle et al.

Article Biochemistry & Molecular Biology

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Jonas Schulte-Schrepping et al.

Article Immunology

Comprehensive mapping of immune perturbations associated with severe COVID-19

Leticia Kuri-Cervantes et al.

SCIENCE IMMUNOLOGY (2020)

Review Medicine, Research & Experimental

Natural history of COVID-19 and current knowledge on treatment therapeutic options

Wagner Gouvea dos Santos

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

Article Biochemistry & Molecular Biology

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Aaron J. Wilk et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Infectious Diseases

Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19

Zhifeng Deng et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Article Biochemistry & Molecular Biology

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Yapeng Su et al.

Article Medicine, Research & Experimental

Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2

Bezawit A. Woldemeskel et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Biochemistry & Molecular Biology

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Fan Zhang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Multidisciplinary Sciences

Most viral peptides displayed by class I MHC on infected cells are immunogenic

Nathan P. Croft et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Biochemistry & Molecular Biology

The Immune Epitope Database (IEDB): 2018 update

Randi Vita et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biochemical Research Methods

Gapped sequence alignment using artificial neural networks: application to the MHC class I system

Massimo Andreatta et al.

BIOINFORMATICS (2016)

Article Microbiology

Kinetics of Antigen Expression and Epitope Presentation during Virus Infection

Nathan P. Croft et al.

PLOS PATHOGENS (2013)

Review Immunology

Towards a systems understanding of MHC class I and MHC class II antigen presentation

Jacques Neefjes et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Review Biochemistry & Molecular Biology

Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets

Nahum Sonenberg et al.

Review Immunology

MHC class I antigen presentation: learning from viral evasion strategies

Ted H. Hansen et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Article Immunology

T cell responses to whole SARS coronavirus in humans

Chris Ka-fai Li et al.

JOURNAL OF IMMUNOLOGY (2008)

Article Biochemistry & Molecular Biology

Reliable prediction of T-cell epitopes using neural networks with novel sequence representations

M Nielsen et al.

PROTEIN SCIENCE (2003)